Clinical Trial: A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Combination With Semaglutide

U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT06972992) titled 'A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Combination With Semaglutide' on May 07.

Brief Summary: This will be a phase I, randomized, double-blind, placebo-controlled. This study will be conducted in three periods: the screening period, the treatment period, and the follow-up period.

Study Start Date: April 18

Study Type: INTERVENTIONAL

Condition: Chronic Weight Management

Intervention: DRUG: ASC47 +Semaglutide

ASC47 single subcutaneous injection + Semaglutide QW for 4 weeks

DRUG: Placebo+Semaglutide

Placebo single subcutaneous injection + Semaglutide QW for 4 weeks

Recruitm...